Inventor

KELLY TERENCE A

US11 patents

⚠️ This page may combine multiple inventors who share the name “KELLY TERENCE A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INHIBIKASE THERAPEUTICS INC

7 patents

US10906896B2Feb 2, 2021

Compositions and methods for inhibiting kinases

INHIBIKASE THERAPEUTICS INC3 citations82

US10344027B2Jul 9, 2019

Compositions and methods for inhibiting kinases

INHIBIKASE THERAPEUTICS INC4 citations82

US10118923B2Nov 6, 2018

Compositions and methods for inhibiting kinases

INHIBIKASE THERAPEUTICS INC6 citations82

US9828370B2Nov 28, 2017

Compositions and methods for inhibiting kinases

INHIBIKASE THERAPEUTICS INC7 citations82

US11407747B2Aug 9, 2022

Compositions and methods for inhibiting kinases

INHIBIKASE THERAPEUTICS INC2 citations71

US10316031B2Jun 11, 2019

Compositions and methods for inhibiting kinases

INHIBIKASE THERAPEUTICS INC2 citations71

US11725005B2Aug 15, 2023

Compositions and methods for inhibiting kinases

INHIBIKASE THERAPEUTICS INC0 citations60

BOEHRINGER INGELHEIM PHARMA

4 patents

US5532358AJul 2, 1996

Method for preparing alkyl-5,11-dihydro-6h-dipyrido[3,2-B:2',3'-E] [1,4] diazepin-6-ones

BOEHRINGER INGELHEIM PHARMA35 citations91

US6355664B1Mar 12, 2002

Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease

BOEHRINGER INGELHEIM PHARMA46 citations89

US7462637B2Dec 9, 2008

Derivatives of [6,7-dihydro-5H-imidazo[1,2--a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide

BOEHRINGER INGELHEIM PHARMA6 citations72

USRE38132EJun 3, 2003

Phenylpyrrolidines, phenylimidazolidines,3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease

BOEHRINGER INGELHEIM PHARMA1 citations49